Back to results
US 7,731,966 B2Granted
Monoclonal antibodies against β3 integrins
AssigneeCanadian Blood Services
InventorsHeyu Ni, Guangheng Zhu
Life of this patent
Estimating the term…
Abstract
Monoclonal antibodies prepared against platelet β3 integrin useful in antithrombotic therapy or in models of thrombosis, thrombocytopenia, and anti-angiogenesis. The antibodies are prepared using β3 integrin deficient (β3−/−) mice immunized against platelets or β3 integrin fragments.
Claims23
A hybridoma cell line having International Depositary Authority of Canada (IDAC) Accession No. selected from 230507-03, 230507-01, 230507-02, 230507-08, 190607-03, 190607-05, 190607-01, 190607-02, 230507-04, 230507-05, 230507-06 and 230507-07.
Dependencies are inferred from the claim text.